ClinConnect ClinConnect Logo
Search / Trial NCT06886698

MRI Assesment of Cerebral Blood Flow in Anesthetized Children

Launched by KAROLINSKA INSTITUTET · Mar 19, 2025

Trial Information

Current as of May 10, 2025

Not yet recruiting

Keywords

Anesthesia Bloodflow Brain Children

ClinConnect Summary

This clinical trial is studying how treatments that raise blood pressure during sedation affect blood flow to the brain in children having an MRI. When children are sedated for an MRI, they often experience a drop in blood pressure, which can affect how well their brain receives blood. The researchers want to find out if the common practice of treating low blood pressure actually helps improve blood flow to the brain, since previous studies in adults showed that even when blood pressure returned to normal, brain blood flow sometimes decreased.

The trial is open to children aged 6 months to 12 years who are scheduled for a brain MRI. However, children with certain conditions, such as known brain tumors or specific brain abnormalities, cannot participate. If your child is eligible and chooses to take part, they will receive standard care during their MRI, and their blood flow will be monitored using advanced MRI technology. This study aims to improve our understanding of how to keep children's brains healthy during sedation for medical imaging.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • children aged 6 months to 12 years
  • Planned to undergo MRI brain
  • * Exclusion Criteria:
  • known brain tumor
  • vascular malformation in the brain
  • hydrocephalus

About Karolinska Institutet

Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.

Locations

Solna, , Sweden

Patients applied

0 patients applied

Trial Officials

Jacob Karlsson, MD PhD Associate Professor

Principal Investigator

Karolinska Universitets Sjukhuset

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported